Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices

Journal of Cell Science

Volumn 114, Issue 5, 2001, Pages 917-930

  Davis, G E ^a   Pintar Allen, K A ^a   Salazar, R ^a   Maxwell, S A ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Collagen gel contraction; Endothelial cell; Matrix metalloproteinase; Morphogenesis; Plasminogen; Regression

Indexed keywords

ACTIN; ADAPTOR PROTEIN; APROTININ; CASPASE 3; COLLAGEN GEL; FOCAL ADHESION KINASE; GELATINASE B; GELSOLIN; INTERSTITIAL COLLAGENASE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR DERIVATIVE; PROTEIN P130; PROTEINASE INHIBITOR; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; CAPILLARY; CELL CULTURE; CELL MATURATION; COLLAGEN METABOLISM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME MECHANISM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TUBE;

ANTIBODIES; APOPTOSIS; BASE SEQUENCE; COLLAGEN; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035060384     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. 2-terminal kinase
2. The sequence of events in the regression of corneal capillaries
3. Apposition-dependent induction of plasminogen activator type I expression: A mechanism for balancing pericellular proteolysis during angiogenesis
4. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
5. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the αvβ3 and α5β1 integrins
6. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
7. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
8. 2-terminal end of the activated enzyme
9. Reconstituted rat-tail collagen used as a substrate for tissue cultures on coverslips in Maximov slides and roller tubes
10. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors
11. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
12. Requirement of vascular integrin αvβ3 for angiogenesis
13. The hemostatic system as regulator of angiogenesis
14. Development and disease in proteinate-deficient mice: Role of the plasminogen, matrix metallproteinase and coagulation system
15. Wound repair: Overview and general considerations
16. A latent Mr94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: A member of the collagenase family of enzymes
17. Regulation of endothelial cell morphogenesis by integrins, mechanical forces and matrix guidance pathways
18. An α2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix
19. Capillary morphogenesis during endothelial cell invasion of three-dimensional collagen matrices. In vitro Cell
20. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2
21. Interstitial collagenase is required for angiogenesis in vitro
22. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate (PMA): A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase
23. Angiogenesis and angiogenesis inhibition: An overview
24. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-hydroxyamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide
25. Three-dimensional type I collagen lattices induced coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
26. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis
27. Annexin II: A mediator of the plasmin/plasminogen activator system
28. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
29. Signaling vascular morphogenesis and maintenance
30. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase
31. A simplified system for generating recombinant adenoviruses
32. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity
33. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
34. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
35. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
36. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinase 1, 2 and 3
37. Expression of SPARC during development of the chicken chorioallantoic membrane: Evidence for regulated proteolysis in vivo
38. Interstitial collagenases
39. A cloning method for caspase substrates that uses the yeast two-hybrid system: Cloning of the antiapoptotic gene gelsolin
40. Membrane-type matrix metalloproteinases and cell surface-associated activation cascades for matrix metalloproteinases
41. Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells
42. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
43. Multiple forms of angiostatin induce apoptosis in endothelial cells
44. Functional overlap between two classes of matrix-degrading proteases in wound healing
45. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization
46. Urinary type IV collagenase: Elevated levels are associated with bladder transitional cell carcinoma
47. Biological and molecular characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis
48. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines
49. The extracellular matrix as a cell survival factor
50. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
51. Plasminogen activators and angiogenesis
52. Proteinases and tissue remodeling
53. Tumor-promoting phorbol esters induce angiogenesis in vitro
54. Identification of an inhibitor of neovascularization from cartilage
55. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing
56. The regulation of neovascularization by matrix metalloproteinases and their inhibitors
57. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro
58. Matrix metalloproteinases
59. Fibrinolysis and the plasma carboxypeptidase
60. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids
61. Proteolytic activation of the precursor of membrane type I matrix metalloproteinase by human plasmin: A possible cell surface activator
62. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma
63. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
64. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis
65. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition
66. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
67. Plasma carboxypeptidases as regulators of the plasminogen system
68. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells
69. A novel signaling molecule, p130, forms stable complexes in vivo with v-crk and v-src in a tyrosine phosphorylation-dependent manner
70. Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein and profilin during capillary morphogenesis in vitro
71. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis
72. Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells
73. A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction
74. Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines
75. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins
76. 72 kD and 92 kD type IV collagenase, type IV collagen and laminin mRNAs in breast cancer: A study by in situ hybridization
77. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
78. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
79. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
80. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
81. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro
82. Between molecules and morphology: Extracellular matrix and the creation of vascular form
83. Contraction of fibrillar type I collagen by endothelial cells: A study in vitro
84. Structure, regulation and function
85. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
86. Extracellular matrix remodelling and the regulation of epithelial-stromal interactions during differentiation and involution
87. Matrix-degrading proteases and angiogenesis during development and tumor formation
88. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation: Regulation by TIMP-2 and TIMP-3
89. 72-kDa gelatinase (gelatinase A): Structure, activation, regulation and substrate specificity
90. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis